INFLAMMATORY MARKERS PREDICT QUALITY OF LIFE AND OVERALL SURVIVAL IN PATIENTS WITH PANCREATIC CANCER UNDERGOING CHEMOTHERAPY: A LONGITUDINAL OBSERVATIONAL STUDY